1. A consensus statement on the gender perspective in lung cancer

   • D. Isla
   • M. Majem
   • J. de Castro

   Review Article 24 November 2016 Pages: 527 - 535

   

2. Gastrointestinal stromal tumors (GISTs): SEAP–SEOM consensus on pathologic and molecular diagnosis

   • J. Martin-Broto
   • V. Martinez-Marín
   • R. González-Cámpora

   Special Article 09 December 2016 Pages: 536 - 545

   

3. MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1

   • X. Ding
   • Y. Yang
   • X. Zhou

   Research Article 14 October 2016 Pages: 546 - 552

   

4. Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer

   • A. J. Conde-Moreno
   • G. Herrando-Parreño
   • C. Ferrer-Albiach

   Research Article 31 October 2016 Pages: 553 - 561

   

5. Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2

   • Q. Li
   • S. Lu
   • B. Qiao

   Research Article 05 December 2016 Pages: 562 - 570

   

6. CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker

   • J. Banerjee
   • R. Pradhan
   • A. B. Dey

   Research Article 04 November 2016 Pages: 571 - 578

   

7. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours

   • V. Clay
   • G. Papaxoinis
   • W. Mansoor

   Research Article 15 November 2016 Pages: 579 - 586

   

8. Knockdown of OCT4 may sensitize NSCLC cells to cisplatin

   • X. Liu
   • M. Ma
   • M. Yang

   Research Article 10 November 2016 Pages: 587 - 592

   

9. Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy

   • R. Mazzola
   • F. Ricchetti
   • F. Alongi

   Research Article 16 November 2016 Pages: 593 - 598

   

10. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer

    • L. Ke
    • S.-B. Xu
    • M.-Q. Xu

    Research Article 22 November 2016 Pages: 599 - 605

    

11. HER2 mRNA transcript quantitation in breast cancer

    • K. Meehan
    • B. Clynick
    • W. N. Erber

    Research Article 11 November 2016 Pages: 606 - 615

    

12. A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)

    • A. González
    • A. Lluch
    • A. Llombart

    Research Article 16 November 2016 Pages: 616 - 624

13. Candidate predisposing germline copy number variants in early onset colorectal cancer patients

    • A. J. Brea-Fernandez
    • C. Fernandez-Rozadilla
    • C. Ruiz-Ponte

    Research Article 25 November 2016 Pages: 625 - 632

    

14. A novel signaling role for miR-451 in esophageal tumor microenvironment and its contribution to tumor progression

    • S. Khazaei
    • N. Nouraee
    • S. J. Mowla

    Research Article 28 November 2016 Pages: 633 - 640

    

15. Imaging findings of adrenal primitive neuroectodermal tumors: a series of seven cases

    • Y. Zhang
    • P. Cai
    • Y. Li

    Research Article 23 November 2016 Pages: 641 - 649

    

16. Erratum to: Gastrointestinal stromal tumors (GISTs): SEAP–SEOM consensus on pathologic and molecular diagnosis

    • J. Martin-Broto
    • V. Martinez-Marín
    • R. González-Cámpora

    Erratum 30 January 2017 Pages: 650 - 650